Ayr Wellness(TSE:AYR.A)
CA$0.160.00 (0.00%)
TSE:AYR.A
Ayr Wellness financials statements
CA$0.16
At close:0.00 (0.00%)
Want to see TSE:AYR.A full AI Analyst Report?
Ayr Wellness (AYR.A) Ratios
71 Followers
Ayr Wellness Ratios
TSE:AYR.A's free cash flow for Q1 2025 was $5.96M. For the 2025 fiscal year, TSE:AYR.A's free cash flow was decreased by $-4.77M and operating cash flow was $10.73M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.60 | 0.96 | 0.93 | 1.75 | 3.05 |
| Quick Ratio | 0.57 | 0.43 | 0.43 | 1.13 | 2.36 |
| Cash Ratio | 0.32 | 0.25 | 0.35 | 1.01 | 2.20 |
| Solvency Ratio | -0.30 | -0.20 | -0.18 | 0.05 | -0.34 |
| Operating Cash Flow Ratio | 0.09 | 0.14 | -0.15 | -0.18 | 0.63 |
| Short-Term Operating Cash Flow Coverage | 0.39 | 1.17 | -0.84 | -3.42 | 4.22 |
| Net Current Asset Value | $ -729.15M | $ -695.98M | $ -715.03M | $ -573.78M | $ -288.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.41 | 0.35 | 0.26 | 0.31 |
| Debt-to-Equity Ratio | 1.64 | 1.03 | 0.75 | 0.47 | 1.26 |
| Debt-to-Capital Ratio | 0.62 | 0.51 | 0.43 | 0.32 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.50 | 0.41 | 0.33 | 0.27 | 0.51 |
| Financial Leverage Ratio | 3.34 | 2.51 | 2.12 | 1.82 | 4.08 |
| Debt Service Coverage Ratio | -1.92 | 0.59 | -1.59 | 2.37 | -0.56 |
| Interest Coverage Ratio | -2.06 | -0.94 | -7.95 | -3.38 | 3.92 |
| Debt to Market Cap | 8.20 | 3.20 | 5.51 | 0.44 | 0.25 |
| Interest Debt Per Share | 6.32 | 8.60 | 9.50 | 8.73 | 6.98 |
| Net Debt to EBITDA | -3.79 | 6.47 | -8.00 | 3.76 | 3.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.11% | 43.66% | 40.90% | 38.62% | 66.47% |
| EBIT Margin | -51.94% | -1.37% | -30.88% | 8.07% | 0.44% |
| EBITDA Margin | -33.33% | 18.25% | -14.53% | 24.52% | 11.10% |
| Operating Profit Margin | -34.72% | -8.03% | -52.19% | -15.66% | 10.39% |
| Pretax Profit Margin | -68.82% | -9.87% | -45.12% | 3.44% | -97.97% |
| Net Profit Margin | -77.50% | -58.76% | -52.72% | -4.74% | -113.68% |
| Continuous Operations Profit Margin | -78.16% | -20.09% | -46.58% | -4.74% | -15.86% |
| Net Income Per EBT | 112.61% | 595.40% | 116.83% | -137.73% | 116.03% |
| EBT Per EBIT | 198.21% | 122.96% | 86.46% | -21.98% | -942.90% |
| Return on Assets (ROA) | -28.31% | -18.66% | -13.92% | -0.91% | -28.63% |
| Return on Equity (ROE) | -94.67% | -46.83% | -29.46% | -1.66% | -116.89% |
| Return on Capital Employed (ROCE) | -13.88% | -2.95% | -15.83% | -3.28% | 2.89% |
| Return on Invested Capital (ROIC) | -13.40% | -2.86% | -15.26% | 4.48% | 2.84% |
| Return on Tangible Assets | -55.07% | -40.20% | -33.58% | -2.60% | -65.02% |
| Earnings Yield | -717.74% | -200.70% | -295.61% | -1.95% | -26.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 35.05 | 34.37 | 60.17 | 48.24 | 43.09 |
| Payables Turnover | 9.29 | 10.87 | 10.32 | 8.14 | 5.84 |
| Inventory Turnover | 2.55 | 2.46 | 2.39 | 2.35 | 1.29 |
| Fixed Asset Turnover | 0.99 | 0.97 | 0.91 | 0.94 | 1.69 |
| Asset Turnover | 0.37 | 0.32 | 0.26 | 0.19 | 0.25 |
| Working Capital Turnover Ratio | 15.83 | -40.80 | 9.48 | 3.08 | 2.72 |
| Cash Conversion Cycle | 114.29 | 125.29 | 123.30 | 117.94 | 229.02 |
| Days of Sales Outstanding | 10.41 | 10.62 | 6.07 | 7.57 | 8.47 |
| Days of Inventory Outstanding | 143.17 | 148.26 | 152.61 | 155.24 | 283.00 |
| Days of Payables Outstanding | 39.29 | 33.59 | 35.38 | 44.87 | 62.45 |
| Operating Cycle | 153.58 | 158.88 | 158.68 | 162.81 | 291.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.09 | 0.37 | -0.50 | -0.48 | 1.31 |
| Free Cash Flow Per Share | -0.14 | -0.17 | -1.41 | -2.23 | 0.78 |
| Dividend Paid and CapEx Coverage Ratio | 0.39 | 0.69 | -0.55 | -0.28 | 2.47 |
| Capital Expenditure Coverage Ratio | 0.39 | 0.69 | -0.55 | -0.28 | 2.47 |
| Operating Cash Flow Coverage Ratio | 0.02 | 0.05 | -0.05 | -0.06 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.06 | -0.07 | -0.08 | 0.24 |
| Free Cash Flow Yield | -30.24% | -9.16% | -116.41% | -14.73% | 3.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.14 | -0.50 | -0.34 | -51.17 | -3.76 |
| Price-to-Sales (P/S) Ratio | 0.11 | 0.29 | 0.18 | 2.43 | 4.27 |
| Price-to-Book (P/B) Ratio | 0.13 | 0.23 | 0.10 | 0.85 | 4.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.31 | -10.91 | -0.86 | -6.79 | 30.45 |
| Price-to-Operating Cash Flow Ratio | 5.20 | 5.00 | -2.43 | -31.23 | 18.14 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.01 | -0.00 | 0.54 | 0.11 |
| Enterprise Value Multiple | -4.12 | 8.07 | -9.22 | 13.65 | 42.15 |
| Enterprise Value | 636.46M | 682.75M | 624.05M | 1.20B | 725.55M |
| EV to EBITDA | -4.12 | 8.07 | -9.22 | 13.65 | 42.15 |
| EV to Sales | 1.37 | 1.47 | 1.34 | 3.35 | 4.68 |
| EV to Free Cash Flow | -42.05 | -54.89 | -6.46 | -9.37 | 33.37 |
| EV to Operating Cash Flow | 66.08 | 25.13 | -18.27 | -43.09 | 19.87 |
| Tangible Book Value Per Share | -2.27 | -2.85 | -2.88 | -3.29 | -6.95 |
| Shareholders’ Equity Per Share | 3.42 | 7.85 | 12.14 | 17.79 | 5.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.14 | -1.04 | -0.22 | 2.38 | -0.16 |
| Revenue Per Share | 4.18 | 6.26 | 6.78 | 6.24 | 5.56 |
| Net Income Per Share | -3.24 | -3.68 | -3.58 | -0.30 | -6.32 |
| Tax Burden | 1.13 | 5.95 | 1.17 | -1.38 | 1.16 |
| Interest Burden | 1.32 | 7.20 | 1.46 | 0.43 | -221.81 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.36 | 0.00 | 0.00 | 0.38 | 0.41 |
| Stock-Based Compensation to Revenue | 0.04 | 0.04 | 0.10 | 0.08 | 0.20 |
| Income Quality | -0.03 | -0.10 | 0.13 | 1.64 | -0.21 |
Currency in USD
